• $15,348.00
    Market Cap
  • -99.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2022
09/30/2021
09/30/2020
Income Statement
Total Operating Revenue
1,825
+7,200.00%
25
+101.45%
-1,725
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
1,825
+7,200.00%
25
+101.45%
-1,725
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
601,179
-5.45%
635,864
-4.20%
663,749
N/A
Operating Profit
-639,262
+0.53%
-635,864
+24.48%
-510,816
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-36,258
+4.45%
-34,713
-26.22%
-47,050
N/A
Interest Income and Expense and Net
-36,258
+4.45%
-34,713
-26.22%
-47,050
N/A
Total Nonoperating Income and Expense
-36,258
+4.45%
-34,713
-173.78%
47,050
N/A
Income before Taxes
-692,216
-6.58%
-741,007
+17.51%
-630,583
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-639,262
-4.67%
-670,602
-219.84%
559,591
N/A
Net Income from Continuing Operations Applicable to Common
-692,216
-6.58%
-741,007
+17.51%
-630,583
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
153.5M
0.00%
153.5M
0.00%
153.5M
N/A
Diluted Weighted Average Shares
153.5M
0.00%
153.5M
0.00%
153.5M
N/A
Balance Sheet
Cash and Cash Equivalents
14,569
+683.70%
1,859
+36.09%
1,366
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
14,569
+683.70%
1,859
+36.09%
1,366
N/A
Total Current Assets
14,568
+683.65%
1,859
+36.09%
1,366
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
15,493
+236.15%
4,609
+11.30%
4,141
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
520,683
0.00%
520,683
0.00%
520,683
N/A
Total Current Liabilities
5.6M
+13.10%
5.0M
+15.64%
4.3M
N/A
Total Long-Term Debt
335,683
0.00%
335,683
0.00%
335,683
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
5.6M
+13.10%
5.0M
+15.64%
4.3M
N/A
Retained Earnings
16.0M
+4.17%
15.3M
+204.58%
-14.6M
N/A
Total Stockholders Equity
-5.6M
+12.89%
-5.0M
+15.64%
-4.3M
N/A
Total Shares Outstanding
153.5M
0.00%
153.5M
0.00%
153.5M
N/A
Cash Flow
Cash from Operating Activities
-27,291
+13.21%
-24,107
-80.43%
-123,199
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
40,000
+62.60%
24,600
-80.12%
123,750
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-35,028.05%
-98.62%
-2,543,456.00%
-8,689.12%
29,612.52%
N/A
Return on Assets
-6,360.18%
-58.51%
-15,328.05%
-229.51%
11,835.68%
N/A
Return on Equity
12.11%
-16.50%
14.51%
+203.89%
-13.96%
N/A
Revenue Growth
7,200.00%
+6,997.14%
101.45%
+80.10%
56.33%
N/A
Current Ratio
0.003
+550.00%
0.0004
+33.33%
0.0003
N/A
Cash Ratio
0.003
+550.00%
0.0004
+33.33%
0.0003
N/A
Debt-to-Equity Ratio
-0.15
-11.41%
-0.17
-13.52%
-0.20
N/A
Debt-to-Assets Ratio
55.27
-70.25%
185.80
-10.15%
206.80
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow